Ginkgo Bioworks (DNA) Tops Q2 EPS by 13c
Tweet
Share
E-mail
Get Alerts DNA Hot Sheet
Join SI Premium – FREE
Ginkgo Bioworks (NYSE: DNA) reported Q2 EPS of ($0.92), $0.13 better than the analyst estimate of ($1.05). Revenue for the quarter came in at $20 million versus the consensus estimate of $29.9 million.
For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MScience Says Alphabet (GOOGL) Ad Growth Has Moderated in Sept
- HP shares slide as tech giant forecasts 2027 PC market slump
- Evercore lifts Ciena rating on AI-driven optical networking boom
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
